vs
Phathom Pharmaceuticals, Inc.（PHAT）与REPUBLIC BANCORP INC（RBCAA）财务数据对比。点击上方公司名可切换其他公司
REPUBLIC BANCORP INC的季度营收约是Phathom Pharmaceuticals, Inc.的1.6倍（$94.3M vs $57.6M），Phathom Pharmaceuticals, Inc.同比增速更快（94.1% vs 5.3%），REPUBLIC BANCORP INC自由现金流更多（$161.1M vs $-167.0M）
Phathom Pharmaceuticals是一家临床阶段生物制药公司，专注于研发和商业化胃肠道疾病的创新疗法，其核心候选产品针对酸相关疾病、炎症性肠病等适应症，主要服务北美及欧洲地区的患者群体。
肯塔基州共和银行是美国的一家区域性银行控股企业，提供零售及商业银行全品类服务，涵盖个人存贷款、企业融资、按揭产品及财富管理解决方案，主要服务肯塔基州及周边州的个人消费者和中小企业客户。
PHAT vs RBCAA — 直观对比
营收规模更大
RBCAA
是对方的1.6倍
$57.6M
营收增速更快
PHAT
高出88.8%
5.3%
自由现金流更多
RBCAA
多$328.1M
$-167.0M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $57.6M | $94.3M |
| 净利润 | — | $22.8M |
| 毛利率 | 86.7% | — |
| 营业利润率 | — | 29.3% |
| 净利率 | — | 24.2% |
| 营收同比 | 94.1% | 5.3% |
| 净利润同比 | 71.6% | 20.0% |
| 每股收益（稀释后） | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PHATRBCAA
| Q4 25 | $57.6M | $94.3M | ||
| Q3 25 | $49.5M | $93.5M | ||
| Q2 25 | $39.5M | $93.8M | ||
| Q1 25 | $28.5M | $135.8M | ||
| Q4 24 | $29.7M | $89.5M | ||
| Q3 24 | $16.4M | $88.1M | ||
| Q2 24 | $7.3M | $86.9M | ||
| Q1 24 | — | $120.3M |
净利润PHATRBCAA
| Q4 25 | — | $22.8M | ||
| Q3 25 | $-30.0M | $29.7M | ||
| Q2 25 | $-75.8M | $31.5M | ||
| Q1 25 | $-94.3M | $47.3M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | $-85.6M | $26.5M | ||
| Q2 24 | $-91.4M | $25.2M | ||
| Q1 24 | — | $30.6M |
毛利率PHATRBCAA
| Q4 25 | 86.7% | — | ||
| Q3 25 | 87.5% | — | ||
| Q2 25 | 87.2% | — | ||
| Q1 25 | 86.9% | — | ||
| Q4 24 | 87.1% | — | ||
| Q3 24 | 85.6% | — | ||
| Q2 24 | 81.2% | — | ||
| Q1 24 | — | — |
营业利润率PHATRBCAA
| Q4 25 | — | 29.3% | ||
| Q3 25 | -30.8% | 40.4% | ||
| Q2 25 | -151.7% | 43.0% | ||
| Q1 25 | -276.5% | 44.1% | ||
| Q4 24 | — | 25.8% | ||
| Q3 24 | -433.0% | 38.4% | ||
| Q2 24 | -1055.4% | 37.0% | ||
| Q1 24 | — | 32.2% |
净利率PHATRBCAA
| Q4 25 | — | 24.2% | ||
| Q3 25 | -60.5% | 31.8% | ||
| Q2 25 | -191.9% | 33.5% | ||
| Q1 25 | -330.7% | 34.8% | ||
| Q4 24 | — | 21.2% | ||
| Q3 24 | -523.3% | 30.1% | ||
| Q2 24 | -1248.6% | 29.0% | ||
| Q1 24 | — | 25.4% |
每股收益（稀释后）PHATRBCAA
| Q4 25 | — | — | ||
| Q3 25 | $-0.41 | — | ||
| Q2 25 | $-1.05 | — | ||
| Q1 25 | $-1.31 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-1.32 | — | ||
| Q2 24 | $-1.56 | — | ||
| Q1 24 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $130.0M | $220.0M |
| 总债务越低越好 | $209.1M | — |
| 股东权益账面价值 | $-438.2M | $1.1B |
| 总资产 | $259.1M | $7.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PHATRBCAA
| Q4 25 | $130.0M | $220.0M | ||
| Q3 25 | $135.2M | $484.2M | ||
| Q2 25 | $149.6M | $484.8M | ||
| Q1 25 | $212.3M | $793.0M | ||
| Q4 24 | $297.3M | $432.2M | ||
| Q3 24 | $334.7M | $530.9M | ||
| Q2 24 | $276.2M | $400.1M | ||
| Q1 24 | — | $546.4M |
总债务PHATRBCAA
| Q4 25 | $209.1M | — | ||
| Q3 25 | $207.1M | — | ||
| Q2 25 | $205.1M | — | ||
| Q1 25 | $203.2M | — | ||
| Q4 24 | $201.4M | — | ||
| Q3 24 | $175.7M | — | ||
| Q2 24 | $174.4M | — | ||
| Q1 24 | — | — |
股东权益PHATRBCAA
| Q4 25 | $-438.2M | $1.1B | ||
| Q3 25 | $-422.5M | $1.1B | ||
| Q2 25 | $-405.8M | $1.1B | ||
| Q1 25 | $-338.4M | $1.0B | ||
| Q4 24 | $-253.6M | $992.0M | ||
| Q3 24 | $-187.1M | $979.7M | ||
| Q2 24 | $-233.8M | $955.4M | ||
| Q1 24 | — | $935.6M |
总资产PHATRBCAA
| Q4 25 | $259.1M | $7.0B | ||
| Q3 25 | $240.3M | $7.0B | ||
| Q2 25 | $250.2M | $7.0B | ||
| Q1 25 | $294.2M | $7.1B | ||
| Q4 24 | $378.3M | $6.8B | ||
| Q3 24 | $387.0M | $6.7B | ||
| Q2 24 | $319.4M | $6.6B | ||
| Q1 24 | — | $6.9B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-166.8M | $168.2M |
| 自由现金流经营现金流 - 资本支出 | $-167.0M | $161.1M |
| 自由现金流率自由现金流/营收 | -290.0% | 170.9% |
| 资本支出强度资本支出/营收 | 0.4% | 7.5% |
| 现金转化率经营现金流/净利润 | — | 7.37× |
| 过去12个月自由现金流最近4个季度 | $-328.9M | $288.6M |
8季度趋势，按日历期对齐
经营现金流PHATRBCAA
| Q4 25 | $-166.8M | $168.2M | ||
| Q3 25 | $-14.1M | $33.3M | ||
| Q2 25 | $-62.7M | $8.4M | ||
| Q1 25 | $-84.9M | $93.2M | ||
| Q4 24 | $-266.8M | $149.0M | ||
| Q3 24 | $-63.6M | $51.3M | ||
| Q2 24 | $-70.7M | $4.0M | ||
| Q1 24 | — | $71.2M |
自由现金流PHATRBCAA
| Q4 25 | $-167.0M | $161.1M | ||
| Q3 25 | $-14.1M | $30.8M | ||
| Q2 25 | $-62.8M | $5.2M | ||
| Q1 25 | $-84.9M | $91.6M | ||
| Q4 24 | $-266.9M | $143.2M | ||
| Q3 24 | $-63.6M | $49.8M | ||
| Q2 24 | $-70.8M | $2.7M | ||
| Q1 24 | — | $69.1M |
自由现金流率PHATRBCAA
| Q4 25 | -290.0% | 170.9% | ||
| Q3 25 | -28.6% | 32.9% | ||
| Q2 25 | -159.0% | 5.5% | ||
| Q1 25 | -297.9% | 67.4% | ||
| Q4 24 | -899.8% | 160.0% | ||
| Q3 24 | -389.0% | 56.5% | ||
| Q2 24 | -966.2% | 3.1% | ||
| Q1 24 | — | 57.5% |
资本支出强度PHATRBCAA
| Q4 25 | 0.4% | 7.5% | ||
| Q3 25 | 0.1% | 2.6% | ||
| Q2 25 | 0.2% | 3.5% | ||
| Q1 25 | 0.1% | 1.2% | ||
| Q4 24 | 0.5% | 6.5% | ||
| Q3 24 | 0.3% | 1.7% | ||
| Q2 24 | 0.6% | 1.5% | ||
| Q1 24 | — | 1.7% |
现金转化率PHATRBCAA
| Q4 25 | — | 7.37× | ||
| Q3 25 | — | 1.12× | ||
| Q2 25 | — | 0.27× | ||
| Q1 25 | — | 1.97× | ||
| Q4 24 | — | 7.84× | ||
| Q3 24 | — | 1.93× | ||
| Q2 24 | — | 0.16× | ||
| Q1 24 | — | 2.33× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
